Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with long-acting G-CSF in patients treated with chemotherapy in Germany: results of the epidemiological cross-sectional survey "G-CSF Day"

被引：0
|
作者：
Egerer, G. [1 ]
Uleer, C. [2 ]
Klausmann, M. [3 ]
Lueck, A. [4 ]
Schroeder, J. [5 ]
Schulz, H. [6 ]
Fichter, C. [7 ]
von der Heyde, E. [8 ]
Voss, P. [9 ]
Worth, G. [10 ]
Burbeck, M. [7 ]
Sahlmann, J. [7 ]
Potthoff, K. [7 ]
机构：
[1] Univ Klinikum Heidelberg, Heidelberg, Germany
[2] Praxisgemeinschaft Gynakol Onkol & Spezielle Oper, Hildesheim, Germany
[3] Studienzentrum Aschaffenburg, Aschaffenburg, Germany
[4] Zentrum Urol & Onkol, Rostock, Germany
[5] Praxis Hamatol & Onkol, Mulheim, Germany
[6] Praxis Internist Onkol & Hamatol PIOH, Frechen, Germany
[7] iOMEDICO AG, Freiburg, Germany
[8] Onkol Schwerpunktpraxis, Hannover, Germany
[9] AMGEN GmbH, Munich, Germany
[10] AMGEN GmbH, Zug, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P942
引用
收藏
页码：261 / 261
页数：1
相关论文
共 50 条
  • [1] G-CSF prophylaxis of febrile neutropenia and infections after chemotherapy
    Link, H.
    [J]. ONKOLOGE, 2014, 20 (03): : 268 - 270
  • [2] Chemotherapy-induced febrile neutropenia: primary G-CSF prophylaxis indicated during docetaxel cycles
    van Dooijeweert, C.
    van der Wall, E.
    Baas, I. O.
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 2019, 77 (09): : 310 - 316
  • [3] Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations
    Matti Aapro
    Ralph Boccia
    Robert Leonard
    Carlos Camps
    Mario Campone
    Sylvain Choquet
    Marco Danova
    John Glaspy
    Iwona Hus
    Hartmut Link
    Thamer Sliwa
    Hans Tesch
    Vicente Valero
    [J]. Supportive Care in Cancer, 2017, 25 : 3295 - 3304
  • [4] Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations
    Aapro, Matti
    Boccia, Ralph
    Leonard, Robert
    Camps, Carlos
    Campone, Mario
    Choquet, Sylvain
    Danova, Marco
    Glaspy, John
    Hus, Iwona
    Link, Hartmut
    Sliwa, Thamer
    Tesch, Hans
    Valero, Vicente
    [J]. SUPPORTIVE CARE IN CANCER, 2017, 25 (11) : 3295 - 3304
  • [5] G-CSF FOR FEVER AND NEUTROPENIA INDUCED BY CHEMOTHERAPY
    AUCHTER, RM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (04): : 269 - 270
  • [6] History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in cancer patients not receiving G-CSF prophylaxis
    Chao, C.
    Page, J. H.
    Yang, S. -J.
    Rodriguez, R.
    Huynh, J.
    Chia, V. M.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (09) : 1821 - 1829
  • [7] G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients
    Krol, J
    Paepke, S
    Jacobs, VR
    Paepke, D
    Euler, U
    Kiechle, M
    Harbeck, N
    [J]. ONKOLOGIE, 2006, 29 (04): : 171 - 178
  • [8] Role of G-CSF in reducing rates, duration and morbidity of chemotherapy-induced febrile neutropenia
    Curreli, L
    Lampis, B
    Bianchi, A
    Ghiani, M
    Astara, G
    Mantovani, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1019 - 1019
  • [9] G-CSF FOR FEVER AND NEUTROPENIA INDUCED BY CHEMOTHERAPY - REPLY
    CRAWFORD, J
    GLASPY, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (04): : 270 - 270
  • [10] USE OF G-CSF IN CHEMOTHERAPY-INDUCED NEUTROPENIA IN OVARIAN-CANCER PATIENTS
    SCHNOR, S
    KRAFFT, W
    ULLRICH, B
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 1072 - 1073
12345